Drug-loaded PEG-PLGA nanoparticles for cancer treatment
Nanoparticles based on single-component synthetic polymers, such as poly (lactic acid-co-glycolic acid) (PLGA), have been extensively studied for antitumor drug delivery and adjuvant therapy due to their ability to encapsulate and release drugs, as well as passively target tumors. Amphiphilic block...
Main Authors: | Dan Zhang, Lin Liu, Jian Wang, Hong Zhang, Zhuo Zhang, Gang Xing, Xuan Wang, Minghua Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.990505/full |
Similar Items
-
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
by: Bi CC, et al.
Published: (2016-12-01) -
PEG 400:Trehalose Coating Enhances Curcumin-Loaded PLGA Nanoparticle Internalization in Neuronal Cells
by: Isaac H. Caballero-Florán, et al.
Published: (2023-05-01) -
Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study
by: Mengying Yao, et al.
Published: (2024-05-01) -
Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles
by: Heba S. Elsewedy, et al.
Published: (2020-01-01) -
Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin
by: Emiliane Daher Pereira, et al.